Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its price objective reduced by Guggenheim from $165.00 to $163.00 in a report published on Monday,Benzinga reports. They currently have a buy ...
Charlotte Holland said she was lucky her insurance covered the near £19,000 procedure in order to avoid being put on the NHS ...
Needham & Company LLC reiterated their hold rating on shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) in a research report released on Friday,Benzinga reports. Several other equities ...
Baird Medical Investment Holdings Ltd. ("Baird Medical" or the "Company"), a leader in microwave ablation (MWA) technology, remains committed to advancing physician education and recently supported Dr ...
Foresee Pharmaceuticals (TPEx: 6576) ("Foresee") announced today the acceptance of an abstract for presentation at the prestigious American Society of Clinical Oncology, Genitourinary (ASCO-GU) ...
Hosted on MSN12h
Had A Smooth First Pregnancy, But Can’t Conceive Again? The Shocking Reality Of Secondary InfertilityInfertility affects 11% of couples. Secondary infertility occurs after a previous successful pregnancy. Causes include age, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback